Alan C. Mendelson, Esq.
Partner, Latham & Watkins
Alan Mendelson, partner at Latham & Watkins LLP, has served as our outside counsel since 2016. Alan represents emerging and public growth companies, primarily in the life sciences industry. He served as the Co-Chair of the Latham & Watkin’s Emerging Companies Practice from 2001 to 2013 and currently is Co-Chair of the firm’s Life Sciences Industry Group. Mr. Mendelson has handled and supervised a variety of major business transactions, including venture capital financings, private placements, public offerings, mergers and acquisitions, joint ventures, strategic collaborations, and commercial transactions. Mr. Mendelson currently serves on the board of directors of the California Life Sciences Association (CLSA), the board of trustees of the UC Berkeley Foundation, the board of advisors for the UC Berkeley Department of Chemistry, and is a member of the UC Innovation Council. Mr. Mendelson previously served on the board of directors of the Biotechnology Industry Organization (BIO) and Baybio, the board of trustees of The Scripps Research Institute, the board of regents of the University of California, and served as the president of the National Kidney Foundation of Northern California, Inc. and as the president of the Cal Alumni Association.